Our Impact
DDN tells the stories behind the sciences to a focused audience in the drug discovery, drug development, and clinical research markets.
Now is a fantastic time to partner with DDN!
15,000
leads delivered in less
than 12 months
2 million+
emails sent to subscribers
3rd party subscribers
78,614
24.33%
average open rate
4.1 million+
newsletters received by subscribers
31% growth
in less than 12 months
35,000
Print subscribers
15,000
print
20,000
digital
digital
*Publisher’s own data taken from
the May 2023 issue.
58,067
newsletters subscribers
18.2%
average open rate
Our Audience
Our readers are your customers.
We offer a variety of ways to share your message with our audience, from traditional print and banner ads to newsletters, graphics, articles, and webinars. Check it out!
95% of DDN subscribers are involved in the purchasing decisions for lab products and analytical instruments.
– based on data from a 2023 Reader Survey
DDN subscriber job titles and positions
-
39%
Researcher/Staff Scientist
-
25%
Lab Director/Lab Manager/Dept Manager
-
17%
Professor/Assistant/Associate Professor
-
12%
Executive Management CEO/Pres/VP
-
8%
Other
DDN subscriber institution types
-
43%
Commercial/Industrial Laboratory
-
31%
Academic Institution
-
16%
Hospital, Medical Center, Clinical Laboratory
-
4%
Government Laboratory (federal, state, or local)
-
5%
Other
– based on data from a 2023 Reader Survey
Research Areas
Analytical Chemistry
Biochemistry
Bioengineering
Biotechnology
Biopharma
Biophysics
Cancer Research
Cell Biology
Chemistry
Clinical Trials
Computational Biology
Diagnostics
Drug Development
Drug Discovery
Epidemiology
Epigentics
Genetics
Genomics
Immunology
Infectious Disease
Metabolomics
Microbiology
Molecular Diagnostics
Neuroscience
Pathology
Pharmacology
Physiology
Natural Products
Preclinical Studies
Proteomics
Stem Cell Research
Toxicology
Translational Research
Vaccine Research
“I like that the content is informative and scientific and covers a range of interesting topics. I also like that the information is presented in a way that is easily understood for topics I do not have much experience with.”